(Q34093837)

31 July 2017

title

Kawasaki disease with predominant central nervous system involvement (English)

1 reference

31 July 2017

1 reference

Tabarki B

1

1 reference

31 July 2017

Mahdhaoui A

2

1 reference

31 July 2017

Selmi H

3

1 reference

31 July 2017

Yacoub M

4

1 reference

31 July 2017

Essoussi AS

5

1 reference

31 July 2017

publication date

1 September 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

25

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

239-241

1 reference

Neurological complications in Kawasaki disease.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

Acute Hemiplegia in Kawasaki Disease and Infantile Polyarteritis Nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

Subdural effusion in the acute stage of Kawasaki disease (Mucocutaneous lymph node syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

Sensorineural hearing loss associated with Kawasaki disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

Cerebrospinal fluid profile in patients with acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

Corticosteroids in the treatment of the acute phase of Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

Cerebral hypoperfusion during acute Kawasaki disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900290-9

7 January 2021

10.1016/S0887-8994(01)00290-9

Identifiers

DOI

1 reference

release_rl3ybwp6fffdngtavcf646ulfa

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rl3ybwp6fffdngtavcf646ulfa

24 November 2022

mapped directly with Wikidata item

1 reference